News | Breast Density | May 26, 2016

Vermont Passes Breast Density Reporting Law

Notification of dense fibroglandular breast tissue and its consequences will be required for all mammography exams on or after Jan. 15, 2017

Vermont, breast density reporting law, Gov. Peter Shumlin

Vermont, breast density reporting law, Gov. Peter Shumlin

May 26, 2016 — Vermont Gov. Peter Shumlin signed the Dense Breast Tissue Reporting Senate Bill 157 into law this week, adding to the growing list of density reporting laws across the country. The bill was introduced in the Vermont Legislature by Sen. Joe Benning.

The law requires all healthcare facilities performing mammography examinations to include information identifying the patient’s individual breast tissue classification based on the American College of Radiology Breast Imaging-Reporting and Data System (BI-RADS). If the patient is determined to have heterogeneously dense or extremely dense breasts, additional information about the impact of dense fibroglandular tissue on cancer detection must also be included.

The bill gives facilities the capacity to update the language in their notices over time to reflect advances in science and technology, provided they continue to inform on the frequency of dense breast tissue and its effects on cancer detection.

The law takes effect on July 1, 2016, and applies to exams on or after Jan. 15, 2017.

For more information: www.densebreast-info.org

Related Content

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017.

IBM collected a dataset of 52,936 images from 13,234 women who underwent at least one mammogram between 2013 and 2017, and who had health records for at least one year prior to the mammogram. The algorithm was trained on 9,611 mammograms. Image courtesy of Radiology.

Feature | Artificial Intelligence | July 19, 2019 | Michal Chorev
Breast cancer is the global leading cause of cancer-related deaths in women, and the most commonly diagnosed cancer...
Paragon Biosciences Launches Qlarity Imaging to Advance FDA-cleared AI Breast Cancer Diagnosis System

Qlarity Imaging’s software is used to assist radiologists in the assessment and characterization of breast lesions. Imaging features are synthesized by an artificial intelligence algorithm into a single value, the QI score, which is analyzed relative to a database of reference abnormalities with known ground truth. Image courtesy of Business Wire.

Technology | Artificial Intelligence | July 18, 2019
Paragon Biosciences LLC announced the launch of its seventh portfolio company, Qlarity Imaging LLC, which was founded...
FDA Clears Koios DS Breast 2.0 AI-based Software
News | Ultrasound Women's Health | July 11, 2019
Koios Medical announced its second 510(k) clearance from the U.S. Food and Drug Administration (FDA).
SimonMed Imaging Implements ProFound AI for 3-D Tomosynthesis
News | Mammography | July 10, 2019
Arizona-based SimonMed Imaging announced their implementation of the first U.S. Food and Drug Administration (FDA)-...
Therapixel Appoints Matthieu Leclerc-Chalvet as CEO
News | Artificial Intelligence | July 03, 2019
Artificial intelligence (AI) breast cancer screening specialist Therapixel announced the appointment of Matthieu...
GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

GE Healthcare showcases Senographe Pristina Serena featuring its add-on-biopsy kit at the Breast Imaging Symposium. Photo by Greg Freiherr

Feature | Breast Imaging | July 03, 2019 | By Greg Freiherr
Productivity and its enabler — efficiency — guided the display of products at the April...
Countless possibilities can impact the future of global healthcare and AI is the first step toward breakthrough that will change the landscape of personalized medicine
Feature | Women's Health | July 03, 2019 | By Samir Parikh
Contrary to what many people believe,...

Image courtesy of GE Healthcare

Feature | Radiology Business | July 03, 2019 | By Jeffrey Hoffmeister, M.D.
Burnout in the medical profession is not uncommon, particularly as clinicians have become more overwhelmed by growing
iCAD ProFound AI

Image courtesy of iCAD

News | Breast Imaging | June 25, 2019
Use of...